PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Park, J.* ; Tucci, A.* ; Cipriani, V.* ; Demidov, G.* ; Rocca, C.* ; Senderek, J.* ; Velic, A.* ; Lam, T.H.* ; Galanaki, E.* ; Cali, E.* ; Vestito, L.* ; Maroofian, R.* ; Deininger, N.* ; Rautenberg, M.* ; Admard, J.* ; Hahn, G.A.* ; Bartels, C.* ; van Os, N.J.H.* ; Horvath, R.* ; Chinnery, P.F.* ; Tiet, M.Y.* ; Hewamadduma, C.* ; Hadjivassiliou, M.* ; Tofaris, G.K.* ; Wood, S.M.* ; Zarowiecki, M.* ; Wood, N.W.* ; Hayer, S.N.* ; Krauss, J.L.* ; Strom, T.M. ; Sturm, M.* ; van de Warrenburg, B.P.* ; Lerche, H.* ; Synofzik, M.* ; Ossowski, S.* ; Timmann, D.* ; Smedley, D.* ; Riess, O.* ; Schöls, L.* ; Houlden, H.* ; Haack, T.B.* ; Hengel, H.*

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Genet. Med. 24, 2079-2090 (2022)
Verlagsversion DOI PMC
Closed
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Purpose: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative disorder, autosomal recessive spastic paraplegia type 79. In this study, we investigated heterozygous UCHL1 variants on the basis of results from cohort-based burden analyses. Methods: Gene-burden analyses were performed on exome and genome data of independent cohorts of patients with hereditary ataxia and spastic paraplegia from Germany and the United Kingdom in a total of 3169 patients and 33,141 controls. Clinical data of affected individuals and additional independent families were collected and evaluated. Patients’ fibroblasts were used to perform mass spectrometry-based proteomics. Results: UCHL1 was prioritized in both independent cohorts as a candidate gene for an autosomal dominant disorder. We identified a total of 34 cases from 18 unrelated families, carrying 13 heterozygous loss-of-function variants (15 families) and an inframe insertion (3 families). Affected individuals mainly presented with spasticity (24/31), ataxia (28/31), neuropathy (11/21), and optic atrophy (9/17). The mass spectrometry-based proteomics showed approximately 50% reduction of UCHL1 expression in patients’ fibroblasts. Conclusion: Our bioinformatic analysis, in-depth clinical and genetic workup, and functional studies established haploinsufficiency of UCHL1 as a novel disease mechanism in spastic ataxia.
Impact Factor
Scopus SNIP
Altmetric
8.864
2.825
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Gene Burden ; Proteomics ; Spastic Ataxia ; Uchl1
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 1530-0366
e-ISSN 1098-3600
Zeitschrift Genetics in Medicine
Quellenangaben Band: 24, Heft: 10, Seiten: 2079-2090 Artikelnummer: , Supplement: ,
Verlag Lippincott Williams & Wilkins
Verlagsort Baltimore, Md.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Human Genetics (IHG)
POF Topic(s) 30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500700-001
Förderungen Deutsche Forschungsgemeinschaft
Medical Research Council
DOI 10.1016/j.gim.2022.07.006
WOS ID WOS:000879580900009
Scopus ID 85136311966
PubMed ID 35986737
Erfassungsdatum 2022-11-14
[➜Korrektur melden]